What is the target range for the use of LMWHs to treat VTE?
The target range for the use of LMWHs to treat VTE is 0.6-1.0 Anti-Xa units/mL for twice daily enoxaparin and nadroparin, 1.05 for once daily dalteparin, 1.0 for once daily enoxaparin, 1.3 for once daily nadroparin, and 0.85 for once daily tinzaparin. These ranges are measured 4 hours after LMWH administration. 